Kaletra

Active Ingredient(s): Lopinavir + Ritonavir
FDA Approved: * September 15, 2000
Pharm Company: * ABBOTT
Category: HIV / AIDS

Lopinavir/ritonavir (LPV/r), sold under the brand name Kaletra among others, is a fixed-dose combination antiretroviral medication for the treatment and prevention of HIV/AIDS.[2] It combines lopinavir with a low dose of ritonavir.[2] It is generally recommended for use with other antiretrovirals.[2] It may be used for prevention after a needlestick injury or other potential exposure.[2] It is taken by mouth as a tablet, capsule,... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Kaletra a;KC
Kaletra 100 mg / 25 mg Oral Tablet
NDC: 0074-0522
Labeler:
Abbvie Inc.
Kaletra a;KA
Kaletra 200 mg / 50 mg Oral Tablet
NDC: 0074-6799
Labeler:
Abbvie Inc.
Kaletra a;KA
Kaletra Oral Tablet, Film Coated
NDC: 24236-676
Labeler:
Remedyrepack Inc.
Kaletra a;KA
Kaletra Oral Tablet, Film Coated
NDC: 54569-5752
Labeler:
A-s Medication Solutions
Kaletra a;KA
Kaletra Oral Tablet, Film Coated
NDC: 70518-0091
Labeler:
Remedyrepack Inc.
Kaletra Oral Tablet, Film Coated
NDC: 0074-1575
Labeler:
Abbvie Inc.
Kaletra Oral Tablet, Film Coated
NDC: 0074-2605
Labeler:
Abbvie Inc.
Kaletra Oral Solution
NDC: 0074-3956
Labeler:
Abbvie Inc.
Kaletra 200 mg / 50 mg Oral Tablet
NDC: 11819-342
Labeler:
Hhs/Program Support Center/Supply Service Center
Kaletra 200 mg / 50 mg Oral Tablet
NDC: 21695-362
Labeler:
Rebel Distributors Corp